UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes

International journal of pharmaceutics, 2008-04, Vol.354 (1), p.56-62

2008

Volltextzugriff (PDF)

The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage

Journal of controlled release, 2013-11, Vol.172 (1), p.38-47

2013

Volltextzugriff (PDF)

Anti-PEG IgM Is a Major Contributor to the Accelerated Blood Clearance of Polyethylene Glycol-Conjugated Protein

Molecular pharmaceutics, 2015-07, Vol.12 (7), p.2429-2435

2015

Volltextzugriff (PDF)

Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes

Journal of controlled release, 2007-06, Vol.119 (2), p.236-244

2007

Volltextzugriff (PDF)

Anti-polyethyleneglycol Antibody Response to PEGylated Substances

Biological and Pharmaceutical Bulletin, 2013/06/01, Vol.36(6), pp.889-891

2013

Volltextzugriff (PDF)

Intravenous Administration of Polyethylene Glycol-Coated (PEGylated) Proteins and PEGylated Adenovirus Elicits an Anti-PEG Immunoglobulin M Response

Biological and Pharmaceutical Bulletin, 2012/08/01, Vol.35(8), pp.1336-1342

2012

Volltextzugriff (PDF)

Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration

International journal of pharmaceutics, 2013-11, Vol.456 (1), p.235-242

2013

Volltextzugriff (PDF)

Accelerated blood clearance of PEGylated liposomes containing doxorubicin upon repeated administration to dogs

International journal of pharmaceutics, 2012-10, Vol.436 (1-2), p.636-643

2012

Volltextzugriff (PDF)

Accelerated blood clearance of PEGylated liposomes upon repeated injections: Effect of doxorubicin-encapsulation and high-dose first injection

Journal of controlled release, 2006-10, Vol.115 (3), p.251-258

2006

Volltextzugriff (PDF)

Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes

Journal of controlled release, 2006-10, Vol.115 (3), p.243-250

2006

Volltextzugriff (PDF)

Transport of PEGylated liposomes from the splenic marginal zone to the follicle in the induction phase of the accelerated blood clearance phenomenon

Immunobiology (1979), 2013-05, Vol.218 (5), p.725-732

2013

Volltextzugriff (PDF)

Influence of dose and animal species on accelerated blood clearance of PEGylated liposomal doxorubicin

International journal of pharmaceutics, 2014-12, Vol.476 (1-2), p.205-212

2014

Volltextzugriff (PDF)

Anti-PEG IgM production by siRNA encapsulated in a PEGylated lipid nanocarrier is dependent on the sequence of the siRNA

Journal of controlled release, 2011-04, Vol.151 (2), p.149-154

2011

Volltextzugriff (PDF)

Relationship between the Concentration of Anti-polyethylene Glycol (PEG) Immunoglobulin M (IgM) and the Intensity of the Accelerated Blood Clearance (ABC) Phenomenon against PEGylated Liposomes in Mice

Biological and Pharmaceutical Bulletin, 2015/03/01, Vol.38(3), pp.417-424

2015

Volltextzugriff (PDF)

Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes

Journal of controlled release, 2006-05, Vol.112 (1), p.15-25

2006

Volltextzugriff (PDF)

The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of PEGylated liposomes in rats

Journal of controlled release, 2008-03, Vol.126 (2), p.162-165

2008

Volltextzugriff (PDF)

Targeting Anticancer Drugs to Tumor Vasculature Using Cationic Liposomes

Pharmaceutical research, 2010-07, Vol.27 (7), p.1171-1183

2010

Volltextzugriff (PDF)

Alteration of Tumor Microenvironment for Improved Delivery and Intratumor Distribution of Nanocarriers

Biological and Pharmaceutical Bulletin, 2013/05/01, Vol.36(5), pp.692-697

2013

Volltextzugriff (PDF)

Selective Delivery of Oxaliplatin to Tumor Tissue by Nanocarrier System Enhances Overall Therapeutic Efficacy of the Encapsulated Oxaliplatin

Biological and Pharmaceutical Bulletin, 2014/02/01, Vol.37(2), pp.206-211

2014

Volltextzugriff (PDF)

Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: Effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes

Journal of controlled release, 2005-07, Vol.105 (3), p.305-317

2005

Volltextzugriff (PDF)

Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells

International journal of pharmaceutics, 2007-02, Vol.329 (1), p.94-102

2007

Volltextzugriff (PDF)

Application of Polyglycerol Coating to Plasmid DNA Lipoplex for the Evasion of the Accelerated Blood Clearance Phenomenon in Nucleic Acid Delivery

Journal of pharmaceutical sciences, 2014-02, Vol.103 (2), p.557-566

2014

Volltextzugriff (PDF)

Effect of siRNA in PEG-coated siRNA-lipoplex on anti-PEG IgM production

Journal of controlled release, 2009-08, Vol.137 (3), p.234-240

2009

Volltextzugriff (PDF)

Accelerated Blood Clearance Phenomenon Upon Repeated Injection of PEG-modified PLA-nanoparticles

Pharmaceutical research, 2009-10, Vol.26 (10), p.2270-2279

2009

Volltextzugriff (PDF)

Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model

Journal of controlled release, 2009-07, Vol.137 (1), p.8-14

2009

Volltextzugriff (PDF)

1 – 25 von 251

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(211)
Mit Volltextzugriff
(239)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(162)
Life Sciences & Biomedicine
(156)
Animals
(139)
Pharmacology & Pharmacy
(130)
Biological And Medical Sciences
(107)
Male
(104)
Medical Sciences
(103)
Pharmacology. Drug Treatments
(96)
General Pharmacology
(88)
Liposomes
(88)
Rats
(83)
Pharmaceutical Technology. Pharmaceutical Industry
(74)
Physical Sciences
(51)
Mice
(49)
Chemistry
(47)
Liposome
(47)
Chemistry, Multidisciplinary
(44)
Rats, Wistar
(43)
Humans
(41)
Polyethylene Glycol
(35)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes

The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage

Anti-PEG IgM Is a Major Contributor to the Accelerated Blood Clearance of Polyethylene Glycol-Conjugated Protein

Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes

Anti-polyethyleneglycol Antibody Response to PEGylated Substances

Intravenous Administration of Polyethylene Glycol-Coated (PEGylated) Proteins and PEGylated Adenovirus Elicits an Anti-PEG Immunoglobulin M Response

Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration

Accelerated blood clearance of PEGylated liposomes containing doxorubicin upon repeated administration to dogs

Accelerated blood clearance of PEGylated liposomes upon repeated injections: Effect of doxorubicin-encapsulation and high-dose first injection

Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes

Transport of PEGylated liposomes from the splenic marginal zone to the follicle in the induction phase of the accelerated blood clearance phenomenon

Influence of dose and animal species on accelerated blood clearance of PEGylated liposomal doxorubicin

Anti-PEG IgM production by siRNA encapsulated in a PEGylated lipid nanocarrier is dependent on the sequence of the siRNA

Relationship between the Concentration of Anti-polyethylene Glycol (PEG) Immunoglobulin M (IgM) and the Intensity of the Accelerated Blood Clearance (ABC) Phenomenon against PEGylated Liposomes in Mice

Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes

The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of PEGylated liposomes in rats

Targeting Anticancer Drugs to Tumor Vasculature Using Cationic Liposomes

Alteration of Tumor Microenvironment for Improved Delivery and Intratumor Distribution of Nanocarriers

Selective Delivery of Oxaliplatin to Tumor Tissue by Nanocarrier System Enhances Overall Therapeutic Efficacy of the Encapsulated Oxaliplatin

Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: Effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes

Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells

Application of Polyglycerol Coating to Plasmid DNA Lipoplex for the Evasion of the Accelerated Blood Clearance Phenomenon in Nucleic Acid Delivery

Effect of siRNA in PEG-coated siRNA-lipoplex on anti-PEG IgM production

Accelerated Blood Clearance Phenomenon Upon Repeated Injection of PEG-modified PLA-nanoparticles

Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model

Suchergebnisse filtern